Glenn J. Lesser, MD
- Professor, Hematology and Oncology
Glenn J. Lesser, MD
Research Interests
- Glioma
- Glioblastoma
- Low-Grade Glioma
- Clinical Trials
- Neuro-Oncology
- Brain Tumors
- Education
- MD, Pennsylvania State University College of Medicine, 1987
- Residency
- Wake Forest Baptist Medical Center, 1988
- Wake Forest Baptist Medical Center, 1990
- Fellowship
- Johns Hopkins Hospital, 1994
- Board Certifications
- American Board of Internal Medicine, Medical Oncology
- Memberships
- American Society of Clinical Oncology
- American Medical Association
- Southern Medical Association
- American College of Physicians Fellow
- Society of Neuro-Oncology
- Southern Association For Oncology
- North Carolina Medical Association
- Positions
- Louise McMichael Miracle Professorship in Oncology
Professor, Hematology and Oncology - Professor, Neurosurgery
- Professor, Public Health Sciences
- Professor, Anesthesiology
- Departments and Affiliations
- Hematology and Oncology
- Neurosurgery
- Public Health Sciences
- Anesthesiology
- Comprehensive Cancer Center
- Cardiovascular Sciences Center
- Hypertension and Vascular Research Center
Research
- The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors. Salz T, Ostroff JS, Nightingale CL, Atkinson TM, Davidson EC, Jinna SR, Kriplani A, Lesser GJ, Lynch KA, Mayer DK, Oeffinger KC, Patil S, Salner AL, Weaver KE. Contemp Clin Trials. 2021 May; 107:106448.
- Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood-Brain Barrier Permeability. Molotkov A, Carberry P, Dolan MA, Joseph S, Idumonyi S, Oya S, Castrillon J, Konofagou EE, Doubrovin M, Lesser GJ, Zanderigo F, Mintz A. Pharmaceutics. 2021 Mar; 13(3)
- A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma. Peereboom DM, Ye X, Mikkelsen T, Lesser GJ, Lieberman FS, Robins HI, Ahluwalia MS, Sloan AE, Grossman SA. Neurosurgery. 2021 01; 88(2):246-251.
- Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors. Ramkissoon LA, Pegram W, Haberberger J, Danziger N, Lesser G, Strowd R, Dahiya S, Cummings TJ, Bi WL, Abedalthagafi M, Sathyan P, McGregor K, Reddy P, Severson E, Williams E, Lin D, Edgerly C, Huang RSP, Hemmerich A, Creeden J, Brown C, Venstrom J, Hegde P, Ross JS, Alexander BM, Elvin J, Ramkissoon SH. Front Neurol. 2020; 11:544680.
- Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Renfrow JJ, Soike MH, West JL, Ramkissoon SH, Metheny-Barlow L, Mott RT, Kittel CA, D'Agostino RB, Tatter SB, Laxton AW, Frenkel MB, Hawkins GA, Herpai D, Sanders S, Sarkaria JN, Lesser GJ, Debinski W, Strowd RE. Sci Rep. 2020 09; 10(1):15195.